121 related articles for article (PubMed ID: 2572960)
1. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein.
Foxwell BM; Mackie A; Ling V; Ryffel B
Mol Pharmacol; 1989 Oct; 36(4):543-6. PubMed ID: 2572960
[TBL] [Abstract][Full Text] [Related]
2. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for cyclosporine.
Ryffel B; Woerly G; Rodriguez C; Foxwell BM
J Recept Res; 1991; 11(1-4):675-86. PubMed ID: 1679456
[TBL] [Abstract][Full Text] [Related]
3. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
4. Expression of the P-glycoprotein gene in multidrug-resistant Chinese hamster ovary cells.
Mukhopadhyay T; Kuo MT
Anticancer Res; 1989; 9(3):575-8. PubMed ID: 2569855
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen aziridine, a novel affinity probe for P-glycoprotein in multidrug resistant cells.
Safa AR; Roberts S; Agresti M; Fine RL
Biochem Biophys Res Commun; 1994 Jul; 202(1):606-12. PubMed ID: 7913604
[TBL] [Abstract][Full Text] [Related]
6. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
Akiyama S; Yoshimura A; Kikuchi H; Sumizawa T; Kuwano M; Tahara Y
Mol Pharmacol; 1989 Nov; 36(5):730-5. PubMed ID: 2573823
[TBL] [Abstract][Full Text] [Related]
7. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
Nare B; Prichard RK; Georges E
Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
[TBL] [Abstract][Full Text] [Related]
8. Preparation and utility of a radioiodinated analogue of daunomycin in the study of multidrug resistance.
Busche R; Tümmler B; Riordan JR; Cano-Gauci DF
Mol Pharmacol; 1989 Apr; 35(4):414-21. PubMed ID: 2565017
[TBL] [Abstract][Full Text] [Related]
9. B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.
Borchers C; Ulrich WR; Klemm K; Ise W; Gekeler V; Haas S; Schödl A; Conrad J; Przybylski M; Boer R
Mol Pharmacol; 1995 Jul; 48(1):21-9. PubMed ID: 7623771
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphorylation in multidrug resistant Chinese hamster cells.
Meyers MB
Cancer Commun; 1989; 1(4):233-41. PubMed ID: 2576975
[TBL] [Abstract][Full Text] [Related]
11. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.
Wang Y; Georges E
Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677
[TBL] [Abstract][Full Text] [Related]
12. Molecular targets in oncology: implications of the multidrug resistance gene.
Lum BL; Gosland MP; Kaubisch S; Sikic BI
Pharmacotherapy; 1993; 13(2):88-109. PubMed ID: 8097038
[TBL] [Abstract][Full Text] [Related]
13. Immunological detection of Chinese hamster ovary cells expressing a multidrug resistance phenotype.
Lathan B; Edwards DP; Dressler LG; Von Hoff DD; McGuire WL
Cancer Res; 1985 Oct; 45(10):5064-9. PubMed ID: 2862990
[TBL] [Abstract][Full Text] [Related]
14. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
Akiyama S; Cornwell MM; Kuwano M; Pastan I; Gottesman MM
Mol Pharmacol; 1988 Feb; 33(2):144-7. PubMed ID: 2893251
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
[TBL] [Abstract][Full Text] [Related]
16. BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport.
Chen HX; Bamberger U; Heckel A; Guo X; Cheng YC
Cancer Res; 1993 May; 53(9):1974-7. PubMed ID: 8097671
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA.
Schurr E; Raymond M; Bell JC; Gros P
Cancer Res; 1989 May; 49(10):2729-33. PubMed ID: 2565763
[TBL] [Abstract][Full Text] [Related]
18. alpha-(3,4-dimethyoxyphenyl)-3,4-dihydro-6,7-dimethoxy-alpha- [(4-methylphenyl)thio]-2(1H)-isoquinolineheptanenitrile (CL 329,753): a novel chemosensitizing agent for P-glycoprotein-mediated resistance with improved biological properties compared with verapamil and cyclosporine A.
Greenberger LM; Collins KI; Annable T; Boni JP; May MK; Lai FM; Kramer R; Citeralla RV; Hallett WA; Powell D
Oncol Res; 1996; 8(5):207-18. PubMed ID: 8884813
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
20. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R
Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
